Identification of N-acyl-fumonisin B1 as new cytotoxic metabolites of fumonisin mycotoxins

Molecular Nutrition and Food Research

Volumn 57, Issue 3, 2013, Pages 516-522

  Harrer, Henning ^a   Laviad, Elad L ^b   Humpf, Hans Ulrich ^a   Futerman, Anthony H ^b  

^a UNIVERSITY OF MÜNSTER   (Germany)

^b WEIZMANN INSTITUTE OF SCIENCE   (Israel)

Author keywords

Fumonisin; Metabolism; Mycotoxin; Sphingolipid

Indexed keywords

DIHYDROCERAMIDE DESATURASE; FUMONISIN; FUMONISIN B1; HYDROLYASE; LACTATE DEHYDRATASE; OXIDOREDUCTASE;

ACYLATION; ARTICLE; CELL CULTURE; CHEMISTRY; FUSARIUM; GENETICS; HUMAN; ISOLATION AND PURIFICATION; METABOLISM;

ACYLATION; CELLS, CULTURED; FUMONISINS; FUSARIUM; HUMANS; HYDRO-LYASES; OXIDOREDUCTASES;

FUSARIUM; MAMMALIA;

EID: 84875054754     PISSN: 16134125     EISSN: 16134133     Source Type: Journal    
DOI: 10.1002/mnfr.201200465     Document Type: Article

References (32)

1. Schwerdt, G., Konigs, M., Holzinger, H., Humpf, H. U. et al., Effects of the mycotoxin fumonisin B(1) on cell death in human kidney cells and human lung fibroblasts in primary culture. J. Appl. Toxicol. 2009, 29, 174-182.
2. Voss, K. A., Riley, R. T., Norred, W. P., Bacon, C. W. et al., An overview of rodent toxicities: liver and kidney effects of fumonisins and Fusarium moniliforme. Environ. Health Persp. 2001, 109, 259-266.
3. Voss, K. A., Norred, W. P., Meredith, F. I., Riley, R. T. et al., Fumonisin concentration and ceramide synthase inhibitory activity of corn, masa, and tortilla chips. J. Toxicol. Env. Health A 2006, 69, 1387-1397.
4. Wild, C. P., Gong, Y. Y., Mycotoxins and human disease: a largely ignored global health issue. Carcinogenesis 2009, 31, 71-82.
5. Wang, E., Norred, W. P., Bacon, C. W., Riley, R. T. et al., Inhibition of sphingolipid biosynthesis by fumonisins. Implications for diseases associated with Fusarium moniliforme. J. Biol. Chem. 1991, 266, 14486-14490.
6. Zitomer, N. C., Mitchell, T., Voss, K. A., Bondy, G. S. et al., Ceramide synthase inhibition by fumonisin B1 causes accumulation of 1-deoxysphinganine: a novel category of bioactive 1-deoxysphingoid bases and 1-deoxydihydroceramides biosynthesized by mammalian cell lines and animals. J. Biol. Chem. 2009, 284, 4786-4795.
7. Merrill, A. H., Jr., Stokes, T. H., Momin, A., Park, H. et al., Sphingolipidomics: a valuable tool for understanding the roles of sphingolipids in biology and disease. J. Lipid Res. 2009, 50, S97-S102.
8. Marasas, W. F., Riley, R. T., Hendricks, K. A., Stevens, V. L. et al., Fumonisins disrupt sphingolipid metabolism, folate transport, and neural tube development in embryo culture and in vivo: a potential risk factor for human neural tube defects among populations consuming fumonisin-contaminated maize. J. Nutr. 2004, 134, 711-716.
9. Pewzner-Jung, Y., Ben-Dor, S., Futerman, A. H., When do Lasses (longevity assurance genes) become CerS (ceramide synthases)?: insights into the regulation of ceramide synthesis. J. Biol. Chem. 2006, 281, 25001-25005.
10. Levy, M., Futerman, A. H., Mammalian ceramide synthases. IUBMB Life 62, 347-356.
11. Koybasi, S., Senkal, C. E., Sundararaj, K., Spassieva, S. et al., Defects in cell growth regulation by C18:0-ceramide and longevity assurance gene 1 in human head and neck squamous cell carcinomas. J. Biol. Chem. 2004, 279, 44311-44319.
12. Futerman, A. H., Hannun, Y. A., The complex life of simple sphingolipids. EMBO Rep. 2004, 5, 777-782.
13. Senkal, C. E., Ponnusamy, S., Rossi, M. J., Bialewski, J. et al., Role of human longevity assurance gene 1 and C18-ceramide in chemotherapy-induced cell death in human head and neck squamous cell carcinomas. Mol. Cancer Ther. 2007, 6, 712-722.
14. Erez-Roman, R., Pienik, R., Futerman, A. H., Increased ceramide synthase 2 and 6 mRNA levels in breast cancer tissues and correlation with sphingosine kinase expression. Biochem. Biophys. Res. Commun. 2010, 391, 219-223.
15. Schiffmann, S., Sandner, J., Birod, K., Wobst, I. et al., Ceramide synthases and ceramide levels are increased in breast cancer tissue. Carcinogenesis 2009, 30, 745-752.
16. Humpf, H. U., Schmelz, E. M., Meredith, F. I., Vesper, H. et al., Acylation of naturally occurring and synthetic 1-deoxysphinganines by ceramide synthase. Formation of N-palmitoyl-aminopentol produces a toxic metabolite of hydrolyzed fumonisin, AP1, and a new category of ceramide synthase inhibitor. J. Biol. Chem. 1998, 273, 19060-19064.
17. Seiferlein, M., Humpf, H. U., Voss, K. A., Sullards, M. C. et al., Hydrolyzed fumonisins HFB1 and HFB2 are acylated in vitro and in vivo by ceramide synthase to form cytotoxic N-acyl-metabolites. Mol. Nutr. Food Res. 2007, 51, 1120-1130.
18. Laviad, E. L., Albee, L., Pankova-Kholmyansky, I., Epstein, S. et al., Characterization of ceramide synthase 2: tissue distribution, substrate specificity, and inhibition by sphingosine 1-phosphate. J. Biol. Chem. 2008, 283, 5677-5684.
19. Cawood, M. E., Gelderblom, W. C. A., Vleggaar, R., Behrend, Y. et al., Isolation of the Fumonisin Mycotoxins - a quantitative approach. J. Agr. Food Chem. 1991, 39, 1958-1962.
20. Wigler, M., Pellicer, A., Silverstein, S., Axel, R., Biochemical transfer of single-copy eucaryotic genes using total cellular DNA as donor. Cell 1978, 14, 725-731.
21. Smith, P. K., Krohn, R. I., Hermanson, G. T., Mallia, A. K. et al., Measurement of protein using bicinchoninic acid. Anal. Biochem. 1985, 150, 76-85.
22. Mizutani, Y., Kihara, A., Igarashi, Y., Mammalian Lass6 and its related family members regulate synthesis of specific ceramides. Biochem. J. 2005, 390, 263-271.
23. Mizutani, Y., Kihara, A., Igarashi, Y., LASS3 (longevity assurance homologue 3) is a mainly testis-specific (dihydro)ceramide synthase with relatively broad substrate specificity. Biochem. J. 2006, 398, 531-538.
24. Laviad, E. L., Albee, L., Pankova-Kholmyansky, I., Epstein, S. et al., Characterization of ceramide synthase 2: tissue distribution, substrate specificity, and inhibition by sphingosine 1-phosphate. J. Biol. Chem. 2008, 283, 5677-5684.
25. Sharma, N., He, Q., Sharma, R. P., Sphingosine kinase activity confers resistance to apoptosis by fumonisin B1 in human embryonic kidney (HEK-293) cells. Chem. Biol. Interact. 2004, 151, 33-42.
26. Hung, W. C., Chang, H. C., Chuang, L. Y., Activation of caspase-3-like proteases in apoptosis induced by sphingosine and other long-chain bases in Hep3B hepatoma cells. Biochem. J. 1999, 338, 161-166.
27. Galvano, F., Russo, A., Cardile, V., Galvano, G. et al., DNA damage in human fibroblasts exposed to fumonisin B(1). Food Chem. Toxicol. 2002, 40, 25-31.
28. Porter, J. K., Voss, K. A., Bacon, C. W., Norred, W. P., Effects of Fusarium moniliforme and corn associated with equine leukoencephalomalacia on rat neurotransmitters and metabolites. Proc. Soc. Exp. Biol. Med. 1990, 194, 265-269.
29. Marasas, W. F., Kellerman, T. S., Gelderblom, W. C., Coetzer, J. A. et al., Leukoencephalomalacia in a horse induced by fumonisin B1 isolated from Fusarium moniliforme. Onderstepoort. J. Vet. Res. 1988, 55, 197-203.
30. Voss, K. A., Norred, W. P., Plattner, R. D., Bacon, C. W., Hepatotoxicity and renal toxicity in rats of corn samples associated with field cases of equine leukoencephalomalacia. Food Chem. Toxicol. 1989, 27, 89-96.
31. Obeid, L. M., Linardic, C. M., Karolak, L. A., Hannun, Y. A., Programmed cell death induced by ceramide. Science 1993, 259, 1769-1771.
32. Heinrich, M., Wickel, M., Winoto-Morbach, S., Schneider-Brachert, W. et al., Ceramide as an activator lipid of cathepsin D. Adv. Exp. Med. Biol. 2000, 477, 305-315.